Abnormal expression of FLOT1 correlates with tumor progression and poor survival in patients with non-small cell lung cancer

被引:31
作者
Li, Hui [1 ]
Wang, Rui-Ming [2 ]
Liu, Shu-Guang [1 ]
Zhang, Jian-Ping [3 ]
Luo, Jing-Yu [1 ]
Zhang, Bai-Jiang [1 ]
Zhang, Xing-Guo [1 ]
机构
[1] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan 250117, Peoples R China
[2] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Dept Clin Lab, Tianjin 300162, Peoples R China
[3] Gen Hosp Jinan Mil Reg, Dept Gen Surg, Jinan 250031, Peoples R China
关键词
FLOT1; NSCLC; Prognosis; FLOTILLIN-1; PROTEIN;
D O I
10.1007/s13277-013-1434-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have revealed that flotillin-1 (FLOT1) plays important roles in cancer progression. However, the role of FLOT1 in development and progression of non-small cell lung cancer (NSCLC) remains largely unknown. The objective of the current study was to investigate the expression pattern and clinicopathological significance of FLOT1 in patients with NSCLC. Real-time quantitative polymerase chain reaction was applied to examine FLOT1 mRNA expression in 52 pairs of NSCLC tissues and adjacent noncancerous tissues. Immunohistochemistry was performed to examine FLOT1 protein expression in paraffin-embedded tissues from 106 NSCLC patients. Statistical analyses were applied to evaluate the diagnostic value and associations of FLOT1 expression with clinicopathological characteristics. FLOT1 mRNA expression was evidently upregulated in NSCLC tissues compared with that in the adjacent noncancerous tissues. In the 106 cases of tested NSCLC samples, FLOT1 protein level was positively correlated with tumor size, tumor stage, and lymph node metastasis. Patients with higher FLOT1 expression had shorter overall survival time, whereas those with lower FLOT1 expression had longer survival time. Taken together, our findings indicate that FLOT1 may play an important role in NSCLC tumorigenesis. Further elucidation of the molecular mechanisms underlying the role of FLOT1 is warranted.
引用
收藏
页码:3311 / 3315
页数:5
相关论文
共 50 条
  • [31] High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
    Lu, Jianjun
    Wang, Yanhong
    Yan, Miansheng
    Feng, Pinning
    Yuan, Linjing
    Cai, Yuesu
    Xia, Xin
    Liu, Min
    Luo, Jinmei
    Li, Laisheng
    ONCOTARGET, 2016, 7 (27) : 41758 - 41766
  • [32] Expression of Chemerin Correlates With a Favorable Prognosis in Patients With Non-Small Cell Lung Cancer
    Zhao, Shen
    Li, Chao
    Ye, Yun-bin
    Peng, Feng
    Chen, Qiang
    LABMEDICINE, 2011, 42 (09): : 553 - 557
  • [33] Nuclear survivin expression is associated with a poor prognosis in Caucasian non-small cell lung cancer patients
    Xie, Yu-lan
    An, Li
    Jiang, Hao
    Wang, Jing
    CLINICA CHIMICA ACTA, 2012, 414 : 41 - 43
  • [34] Forkhead box 1 expression is upregulated in non-small cell lung cancer and correlates with pathological parameters
    Wang, Chongwei
    Wang, Chongbang
    Duan, Shufang
    OPEN LIFE SCIENCES, 2016, 11 (01): : 220 - 224
  • [35] The heterogeneous expression patterns of serum tumor markers in non-small cell lung cancer patients are predictive factors for progression-free survival
    Siqi Li
    Zihang Zeng
    Zixi Hong
    Jiali Li
    Conghua Xie
    Discover Oncology, 16 (1)
  • [36] High miRNA-221 expression is associated with poor overall survival in patients with non-small cell lung cancer
    Liu, Ya
    Wang, Jing
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (07): : 2975 - 2980
  • [37] TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients
    Zhang, Xiupeng
    Han, Shuai
    Zhou, Haijing
    Cai, Lin
    Li, Jingduo
    Liu, Nan
    Liu, Yang
    Wang, Liang
    Fan, Chuifeng
    Li, Ailin
    Miao, Yuan
    MOLECULAR CARCINOGENESIS, 2019, 58 (05) : 767 - 776
  • [38] Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival
    Wang, Yong-Lian
    Yao, Wen-Jian
    Guo, Ling
    Xi, Hui-Fang
    Li, Song-Yue
    Wang, Zhong-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 601 - 607
  • [39] Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis
    Tingting Ni
    Guoxin Mao
    Qun Xue
    Yifei Liu
    Buyou Chen
    Xuefan Cui
    Liting Lv
    Liangliang Jia
    Yuchan Wang
    Lili Ji
    Journal of Molecular Histology, 2015, 46 : 325 - 335
  • [40] Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival
    Bai, Yu
    Wang, Yong-Lian
    Yao, Wen-Jian
    Guo, Ling
    Xi, Hui-Fang
    Li, Song-Yue
    Zhao, Bao-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 824 - 829